Cellosaurus logo
expasy logo

Cellosaurus Hs578T-Dox (CVCL_IR02)

[Text version]
Cell line name Hs578T-Dox
Synonyms Hs578T/Doxo
Accession CVCL_IR02
Resource Identification Initiative To cite this cell line use: Hs578T-Dox (RRID:CVCL_IR02)
Comments Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
Derived from site: In situ; Breast; UBERON=UBERON_0000310.
Sequence variations
  • Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
  • Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
  • Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (from parent cell line).
Disease Invasive breast carcinoma of no special type (NCIt: C4194)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0332 (Hs 578T)
Sex of cell Female
Age at sampling 74Y
Category Cancer cell line
Publications

PubMed=7902062
Manuel de la Torre, Xiao-Yong Hao, Rolf Larsson, Peter Nygren, Takashi Tsuruo, Bengt Mannervik, Jonas Bergh;
Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
Anticancer Res. 13:1425-1430(1993)

PubMed=10571255; DOI=10.1016/S0006-2952(99)00262-2
Osten Jonsson, Parviz Behnam-Motlagh, Mattias Persson, Roger Henriksson, Kjell Grankvist;
Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity.
Biochem. Pharmacol. 58:1801-1806(1999)

PubMed=15239129; DOI=10.1002/ijc.20300
Chuan-Xi Cai, Jian-Wen Chen;
Overexpression of caveolin-1 induces alteration of multidrug resistance in Hs578T breast adenocarcinoma cells.
Int. J. Cancer 111:522-529(2004)

Cross-references
Cell line databases/resources cancercelllines; CVCL_IR02
Encyclopedic resources Wikidata; Q54896337
Entry history
Entry creation03-Mar-2017
Last entry update19-Dec-2024
Version number14